Document Detail

Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses.
MedLine Citation:
PMID:  19338986     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To determine whether the frequency of abnormal results for evidence-based diagnostic tests differed among women with recurrent pregnancy loss (RPL) based on the number of prior losses (n = 2, 3, or > or =4) and to determine whether abnormal results for additional investigative diagnostic tests differed in prevalence among women with different numbers of pregnancy losses. DESIGN: Single-center, retrospective study. SETTING: Patients with RPL at a private practice. PATIENT(S): One thousand twenty women who had two or more consecutive spontaneous pregnancy losses with the same partner. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Frequencies of abnormal results for evidence-based diagnostic tests considered definite or probable causes of RPL (karyotyping for parental chromosomal abnormalities; pelvic sonohysterography, hysterosalpingogram, or hysteroscopy for uterine anomalies; immunological tests for lupus anticoagulant and anticardiolipin antibodies; thrombophilic tests for the factor V Leiden mutation; and blood tests for thyroid-stimulating hormone [TSH] and fasting blood glucose). We also measured the frequency of abnormal results for nine additional investigative tests in the same patients (antiphosphatidyl serine antibodies, microbial infection, midluteal P, PRL, functional protein C activity, functional protein S activity, antithrombin activity, fasting homocysteine and methylenetetrahydrofolate reductase polymorphisms, and factor II mutation). RESULT(S): The prevalence of abnormal results for evidence-based and investigative diagnostic tests did not differ among women with different numbers of pregnancy losses. CONCLUSION(S): Evaluation of all couples with two, three, or more consecutive miscarriages is recommended.
Carolyn R Jaslow; Judi L Carney; William H Kutteh
Related Documents :
17044316 - Recurrent pregnancy loss: evaluation and discussion of the causes and their management.
19550316 - Anticoagulants to prevent placenta-mediated pregnancy complications: a review of curren...
12734676 - Assessment of the 20210 g to a prothrombin variant in a sample of patients from the fre...
9759136 - Osteoporosis during pregnancy and its management.
16939566 - Tissue response and msx1 expression after human fetal digit tip amputation in vitro.
9621306 - Analysis of aneuploidy rate in antral and ovulated mouse oocytes during female aging.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-03-31
Journal Detail:
Title:  Fertility and sterility     Volume:  93     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-01     Completed Date:  2010-04-01     Revised Date:  2010-09-03    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1234-43     Citation Subset:  IM    
Copyright Information:
Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Department of Biology, Rhodes College, University of Tennessee, Memphis, Tennessee, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortion, Habitual / diagnosis*,  genetics,  immunology,  pathology
Blood Glucose / metabolism
Cohort Studies
Diagnostic Tests, Routine* / methods
Middle Aged
Retrospective Studies
Risk Factors
Thyrotropin / blood
Reg. No./Substance:
0/Blood Glucose; 9002-71-5/Thyrotropin
Comment In:
Fertil Steril. 2010 Sep;94(4):e61   [PMID:  20633877 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of two mathematical models for the study of vascular reactivity.
Next Document:  Hypertensive pregnancy complications in poor and normal responders after in vitro fertilization.